Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?

Keyphrases

• New Standards 100%
• Monotherapy 100%
• Locally Advanced Rectal Cancer 100%
• PD-1 Inhibitor 100%
• Colon Cancer 50%
• Colorectal Cancer 50%
• Response to Neoadjuvant Therapy 50%
• Combined Modality Therapy 50%
• Nonoperative Management 50%
• Treatment Course 50%
• Mismatch Repair 50%
• Checkpoint Inhibition 50%
• Clinical Complete Response 50%

Medicine and Dentistry

• Monotherapy 100%
• Rectum Cancer 100%
• Immunotherapy 33%
• Neoadjuvant Therapy 33%
• DNA Mismatch Repair 33%
• Colon Cancer 33%